No significant changes in EGFR and Akt expression in the combination treatment group compared to other individual treatment groups in terms of real-time qPCR and immunoblotting of mouse tumor tissues (Figures 8A, B, E, G). This evidence concerns the gene AKT1 and neoplasm.